The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal …

R Gruber, LJM van Haarlem, SO Warnaar, E Holz… - Cancer Research, 2000 - AACR
Murine monoclonal antibodies (mAbs), when administered to patients, induce a human
antimouse immunoglobulin immune response, especially when multiple infusions are …

Concurrent radiotherapy and tumor targeting with 111In-HMFG1-F (ab') 2 in patients with MUC1-positive non-small cell lung cancer

M Garkavij, M Samarzija, SB Ewers… - Anticancer …, 2005 - ar.iiarjournals.org
Background: Combining external radiotherapy (XRT) and radioimmunotargeting might
enhance tumor radiation without affecting morbidity, due to different toxicity profiles. Aim: To …

Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT®-Tc), a totally human …

BG Wolff, J Bolton, R Baum, A Chetanneau… - Diseases of the colon & …, 1998 - Springer
PURPOSE: The study contained herein was undertaken to evaluate the accuracy of
radiolabeled human monoclonal antibody, 88BV59H21-2V67-66 (88BV59 or …

Immunszintigraphie und Radioimmuntherapie bei gynäkologischen Malignomen

D Elling, V Pink, D Elling, V Pink - Tumormarker und Immunszintigraphie in …, 1992 - Springer
Für die Tumordiagnostik leisten bildgebende Verfahren seit Jahrzehnten einen
wesentlichen Beitrag, wobei Ultraschall-, CT-bzw. MRT-Untersuchungen die klassischen …

[CITATION][C] The incidence of non iatrogenic human anti-mouse antibodies and their possible clinical relevance

RW Lipp, A Passath, G Leb - European Journal of Nuclear Medicine, 1991 - Springer
The parenteral application of murine antibodies for immunoscintigraphy or therapy may give
rise to the synthesis of specific human anti-mouse antibodies (HAMA) that should be …